£121.81

Springer - Theranostics, Gallium-68, and Other Radionuclides

Price data last checked 13 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 78 days • 78 data points (No recent data available)

Historical
Generating forecast...
£138.97 £119.87 £124.04 £128.21 £132.37 £136.54 £140.71 27 January 2026 15 February 2026 06 March 2026 25 March 2026 14 April 2026

Price Distribution

Price distribution over 78 days • 3 price levels

Days at Price
Current Price
40 days · current 14 days 24 days 0 10 20 30 40 £122 £123 £139 Days at Price

Price Analysis

Most common price: £122 (40 days, 51.3%)

Price range: £122 - £139

Price levels: 3 different prices over 78 days

Description

Explore the evolving landscape of molecular targeting with this comprehensive volume from Springer. Based on contributions from the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, this book examines the emerging field of theranostics. It focuses on how vectors can be used for both diagnosis and therapy through specific modifications. Readers will find detailed research regarding the clinical applications of gallium-68 and other generator-produced PET radionuclides. This text is particularly relevant for those studying the personalized diagnosis and treatment of neuroendocrine tumors and various other diseases. By covering new PET radiopharmaceuticals and recent developments, this book provides a deep look into how these tools are shaping modern medical practices in oncology and beyond.

Key Features

Based on expert contributions from the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy.

Covers the field of theranostics, focusing on molecular targeting vectors used for both diagnosis and therapy.

Provides research on the clinical applications of gallium-68 and other generator-produced PET radionuclides.

Addresses personalized diagnosis and treatment methods for neuroendocrine tumors and other diseases.

Includes information on new PET radiopharmaceuticals and recent developments in the field.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
20 September 2014
Listed Since
18 September 2014

Barcode

No barcode data available

Similar Products You Might Like

Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment: 194 (Recent Results in Cancer Research, 194)
98% match

Theranostics, Gallium-68, and Other Radionuclides: A Pathway to Personalized Diagnosis and Treatment: 194 (Recent Results in Cancer Research, 194)

Springer

£138.61 31 Jan 2026
Molecular Radio-Oncology: 198 (Recent Results in Cancer Research, 198)
94% match

Molecular Radio-Oncology: 198 (Recent Results in Cancer Research, 198)

Springer

£65.60 28 Feb 2026
Humana Diagnostic and Therapeutic Nuclear Medicine Guidebook
93% match

Humana Diagnostic and Therapeutic Nuclear Medicine Guidebook

Humana

£111.57 13 Apr 2026
Radioguided Surgery: Current Applications and Innovative Directions in Clinical Practice
93% match

Radioguided Surgery: Current Applications and Innovative Directions in Clinical Practice

Springer

£109.22 10 Mar 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
93% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£151.95 18 Feb 2026
Cancer Imaging with Radiolabeled Antibodies: 51 (Cancer Treatment and Research, 51)
93% match

Cancer Imaging with Radiolabeled Antibodies: 51 (Cancer Treatment and Research, 51)

Springer

£212.92 13 Jan 2026
Radiotheranostics - A Primer for Medical Physicists I: Physics, Chemistry, Biology and Clinical Applications (Series in Medical Physics and Biomedical Engineering)
93% match

Radiotheranostics - A Primer for Medical Physicists I: Physics, Chemistry, Biology and Clinical Applications (Series in Medical Physics and Biomedical Engineering)

CRC Press

£134.63 12 Mar 2026
PET Chemistry: The Driving Force in Molecular Imaging: 62 (Ernst Schering Foundation Symposium Proceedings, 62)
93% match

PET Chemistry: The Driving Force in Molecular Imaging: 62 (Ernst Schering Foundation Symposium Proceedings, 62)

Springer

£107.01 23 Jan 2026
PET Chemistry: The Driving Force in Molecular Imaging: 62 (Ernst Schering Foundation Symposium Proceedings, 62)
93% match

PET Chemistry: The Driving Force in Molecular Imaging: 62 (Ernst Schering Foundation Symposium Proceedings, 62)

Springer

£147.16 25 Jan 2026
Targeted Molecular Imaging (Imaging in Medical Diagnosis and Therapy)
93% match

Targeted Molecular Imaging (Imaging in Medical Diagnosis and Therapy)

CRC Press

£192.44 10 Jan 2026
Personalized Medicine (Beyond Pet Biomarkers) (Biotechnology in Agriculture, Industry and Medicine)
93% match

Personalized Medicine (Beyond Pet Biomarkers) (Biotechnology in Agriculture, Industry and Medicine)

£122.68 03 Feb 2026
Nanotheranostics For Personalized Medicine
93% match

Nanotheranostics For Personalized Medicine

World Scientific Publishing Company

£73.00 09 Mar 2026
Molecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications
93% match

Molecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications

£125.00 11 Jan 2026
New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma (Medical Radiology)
93% match

New Concepts in Diagnosis and Therapy of Pancreatic Adenocarcinoma (Medical Radiology)

Springer

£84.55 09 Jan 2026
Radiopharmaceutical Therapy
93% match

Radiopharmaceutical Therapy

Springer

£170.00 23 Jan 2026
Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy (Current Clinical Pathology)
93% match

Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy (Current Clinical Pathology)

Humana

£88.34 01 Mar 2026
Cancer Theranostics
93% match

Cancer Theranostics

Academic Press

£113.49 28 Mar 2026
Radiobiology of Glioblastoma: Recent Advances and Related Pathobiology: 0 (Current Clinical Pathology)
93% match

Radiobiology of Glioblastoma: Recent Advances and Related Pathobiology: 0 (Current Clinical Pathology)

Humana

£73.51 03 Mar 2026
Pharmaceutical Perspectives of Cancer Therapeutics
93% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£139.95 11 Jan 2026
CRC Press Radiosensitizers and Radiochemotherapy in Cancer
93% match

CRC Press Radiosensitizers and Radiochemotherapy in Cancer

CRC Press

£91.61 15 Apr 2026
Nuclear Medicine Therapy: Principles and Clinical Applications
92% match

Nuclear Medicine Therapy: Principles and Clinical Applications

Springer

£101.71 11 Jan 2026
PET-CT: A Case Based Approach
92% match

PET-CT: A Case Based Approach

Springer

£156.82 12 Jan 2026
Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)
92% match

Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)

Springer

£243.51 09 Dec 2025
Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)
92% match

Radiation Oncology: Radiobiological and Physiological Perspectives: The boundary-zone between clinical radiotherapy and fundamental radiobiology and physiology: 60 (Developments in Oncology, 60)

Springer

£212.92 12 Jan 2026